Clinical and Economic Impact of an Electronic Medical Record Interfaced Decision Support System for Minimizing Severe Drug-Drug Interactions (DDI+)

This study is not yet open for participant recruitment.
Verified January 2013 by Leumit Health Services
Sponsor:
Information provided by (Responsible Party):
Leumit Health Services
ClinicalTrials.gov Identifier:
NCT01765595
First received: January 9, 2013
Last updated: NA
Last verified: January 2013
History: No changes posted
  Purpose

Leumit Health Services, an health maintenance organization operating in Israel, will incorporate a web-based, decision support system for handling drug-drug interactions and drug information, termed DDI+. the investigators hypothesize that implementing such a system will reduce health-care expenditures (e.g., hospital admissions, referrals to ERs, Imaging procedures).


Condition Intervention
Healthcare
Other: DDI+

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research

Resource links provided by NLM:


Further study details as provided by Leumit Health Services:

Primary Outcome Measures:
  • Hospital Admissions [ Time Frame: up to 12 months post initiation ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 150000
Study Start Date: January 2013
Estimated Study Completion Date: June 2014
Estimated Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: DDI+
DDI+ Incorporated in routine ambulatory practice
Other: DDI+
No Intervention: Control
Standard care

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Number of chronic concomitant drugs ≥5

Exclusion Criteria:

  • Patients diagnosed with HIV/AIDS, and/or viral hepatitis B or C.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01765595

Contacts
Contact: Abraham Weizman, MD +972-50-7277123 AWeizman@clalit.org.il

Locations
Israel
Leumit Health Services Not yet recruiting
Tel-Aviv, Israel
Contact: Natan R Kahan, PhD         
Principal Investigator: Abraham Weizman, MD         
Principal Investigator: Mati Berkowitz, MD         
Sponsors and Collaborators
Leumit Health Services
Investigators
Principal Investigator: Abraham Weizman, MD Tel Aviv University
  More Information

No publications provided

Responsible Party: Leumit Health Services
ClinicalTrials.gov Identifier: NCT01765595     History of Changes
Other Study ID Numbers: LHS012013
Study First Received: January 9, 2013
Last Updated: January 9, 2013
Health Authority: Israel: Ministry of Health

Keywords provided by Leumit Health Services:
health care expenditure
drug drug interactions
electronic decision support systems
Potential reduction

ClinicalTrials.gov processed this record on April 17, 2014